{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:07:54Z","timestamp":1788815274276,"version":"build-2803163510"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001236","name":"Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2022-09-32"],"award-info":[{"award-number":["320.6750.2022-09-32"]}],"id":[{"id":"10.13039\/100001236","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172716"],"award-info":[{"award-number":["82172716"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018904","name":"Beijing Xisike Clinical Oncology Research Foundation","doi-asserted-by":"publisher","award":["Y-HR2020MS-0924"],"award-info":[{"award-number":["Y-HR2020MS-0924"]}],"id":[{"id":"10.13039\/100018904","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bcp.2026.118322","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:04:09Z","timestamp":1785942249000},"page":"118322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["How diverse therapeutic strategies reshape the tumor immune microenvironment in small cell lung cancer: from radiation to engineered immunotherapies"],"prefix":"10.1016","volume":"253","author":[{"given":"Zhuoyan","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunrui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangtian","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8421-453X","authenticated-orcid":false,"given":"Shu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118322_b0005","first-page":"620","article-title":"Clinical insights into small cell lung cancer: tumor heterogeneity, diagnosis, therapy, and future directions","volume":"73","author":"Megyesfalvi","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bcp.2026.118322_b0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","article-title":"Small-cell lung cancer","volume":"7","author":"Rudin","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bcp.2026.118322_b0015","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.annonc.2021.02.025","article-title":"Small cell lung cancer: a slightly less orphan disease after immunotherapy","volume":"32","author":"Remon","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bcp.2026.118322_b0020","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1470-2045(22)00224-8","article-title":"Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"23","author":"Wang","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bcp.2026.118322_b0025","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1164\/rccm.202410-1959PP","article-title":"Non-small cell lung cancer to small cell lung cancer transformation: a clinical challenge","volume":"211","author":"Papavassiliou","year":"2025","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bcp.2026.118322_b0030","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1158\/0008-5472.CAN-20-2808","article-title":"Evasion of innate immunity contributes to small cell lung cancer progression and metastasis","volume":"81","author":"Zhu","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118322_b0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41568-018-0081-9","article-title":"The lung microenvironment: an important regulator of tumour growth and metastasis","volume":"19","author":"Altorki","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2026.118322_b0040","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41392-022-01150-4","article-title":"Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancer","volume":"7","author":"Tian","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2026.118322_b0045","doi-asserted-by":"crossref","first-page":"7983","DOI":"10.1002\/jcp.27553","article-title":"Contribution of regulatory T cells to cancer: a review","volume":"234","author":"Najafi","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcp.2026.118322_b0050","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1172\/JCI128644","article-title":"Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8 T cell recruitment","volume":"129","author":"Petty","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bcp.2026.118322_b0055","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2026.118322_b0060","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ccell.2020.10.001","article-title":"The challenges of tumor mutational burden as an immunotherapy biomarker","volume":"39","author":"Jardim","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2026.118322_b0065","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1158\/2159-8290.CD-20-0913","article-title":"Intrinsic immunogenicity of small cell lung carcinoma revealed by its cellular plasticity","volume":"11","author":"Mahadevan","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bcp.2026.118322_b0070","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002554","article-title":"Human leukocyte antigen class ii-based immune risk model for recurrence evaluation in stage I\u2013III small cell lung cancer","volume":"9","author":"Chen","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bcp.2026.118322_b0075","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-021-00496-y","article-title":"Anti-angiogenic agents\u2014overcoming tumour endothelial cell anergy and improving immunotherapy outcomes","volume":"18","author":"Huinen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bcp.2026.118322_b0080","doi-asserted-by":"crossref","first-page":"6859","DOI":"10.1038\/s41467-021-26821-8","article-title":"Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer","volume":"12","author":"Chen","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118322_b0085","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/s41419-022-05336-0","article-title":"NLRP6 is required for cancer-derived exosome-modified macrophage M2 polarization and promotes metastasis in small cell lung cancer","volume":"13","author":"Rao","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2026.118322_b0090","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jtho.2020.09.009","article-title":"SCLC subtypes defined by ASCL1, NEUROD1, POU2F3, and YAP1: a comprehensive immunohistochemical and histopathologic characterization","volume":"15","author":"Baine","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bcp.2026.118322_b0095","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.ccell.2021.09.008","article-title":"Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer","volume":"39","author":"Chan","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2026.118322_b0100","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s42003-021-01842-7","article-title":"Cell-autonomous immune gene expression is repressed in pulmonary neuroendocrine cells and small cell lung cancer","volume":"4","author":"Cai","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bcp.2026.118322_b0105","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/s41419-023-06053-y","article-title":"YAP1 expression is associated with survival and immunosuppression in small cell lung cancer","volume":"14","author":"Chen","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2026.118322_b0110","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ccell.2020.05.001","article-title":"Myc drives temporal evolution of small cell lung cancer subtypes by reprogramming neuroendocrine fate","volume":"38","author":"Ireland","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2026.118322_b0115","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jtho.2023.07.012","article-title":"Lineage plasticity in SCLC generates non-neuroendocrine cells primed for vasculogenic mimicry","volume":"18","author":"Pearsall","year":"2023","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bcp.2026.118322_b0120","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nature08750","article-title":"Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate","volume":"463","author":"Zheng","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118322_b0125","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/s44318-024-00064-x","article-title":"Ferritin heavy chain supports stability and function of the regulatory T cell lineage","volume":"43","author":"Wu","year":"2024","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2026.118322_b0130","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/ni.3365","article-title":"Autophagy enforces functional integrity of regulatory T cells by coupling environmental cues and metabolic homeostasis","volume":"17","author":"Wei","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcp.2026.118322_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109235","article-title":"The glutathione peroxidase GPX4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity","volume":"35","author":"Xu","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2026.118322_b0140","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.immuni.2023.01.010","article-title":"Tissue-specific abundance of interferon-\u03b3 drives regulatory T cells to restrain DC1-mediated priming of cytotoxic T cells against lung cancer","volume":"56","author":"Zagorulya","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2026.118322_b0145","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.jtho.2025.02.029","article-title":"Selective depletion of CCR8+ Treg cells enhances the antitumor immunity of cytotoxic T cells by dendritic cells","volume":"20","author":"Chen","year":"2025","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bcp.2026.118322_b0150","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12943-025-02383-x","article-title":"IFITM3 enhances immunosensitivity via MHC-I regulation and is associated with the efficacy of Anti-PD-1\/-L1 therapy in SCLC","volume":"24","author":"Cui","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2026.118322_b0155","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1158\/2159-8290.CD-18-1020","article-title":"Targeting DNA damage response promotes antitumor immunity through STING-mediated T-cell activation in small cell lung cancer","volume":"9","author":"Sen","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bcp.2026.118322_b0160","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jtho.2023.05.008","article-title":"Clinical benefit from immunotherapy in patients with SCLC is associated with tumor capacity for antigen presentation","volume":"18","author":"Rudin","year":"2023","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bcp.2026.118322_b0165","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3390\/biology10060502","article-title":"Characterization of tumor-associated macrophages and the immune microenvironment in limited-stage neuroendocrine-high and -low small cell lung cancer","volume":"10","author":"Dora","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.bcp.2026.118322_b0170","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.lungcan.2017.01.003","article-title":"The cell\u2013cell interaction between tumor-associated macrophages and small cell lung cancer cells is involved in tumor progression via STAT3 activation","volume":"106","author":"Iriki","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bcp.2026.118322_b0175","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.canlet.2020.11.034","article-title":"Epigenetic silencing of chemokine CCL2 represses macrophage infiltration to potentiate tumor development in small cell lung cancer","volume":"499","author":"Zheng","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2026.118322_b0180","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12890-025-03533-z","article-title":"\u03b2-elemene inhibits tumor-promoting in small cell lung cancer by affecting M2 macrophages and TGF-\u03b2","volume":"25","author":"Huang","year":"2025","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.bcp.2026.118322_b0185","doi-asserted-by":"crossref","first-page":"213","DOI":"10.32604\/or.2024.046895","article-title":"Ubiquitin-specific protease 1 facilitates tumor immune escape from natural killer cells and predicts the prognosis in small cell lung cancer","volume":"33","author":"Jiang","year":"2024","journal-title":"Oncol. Res."},{"key":"10.1016\/j.bcp.2026.118322_b0190","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/s44321-024-00108-z","article-title":"Therapeutic targeting ERR\u03b3 suppresses metastasis via extracellular matrix remodeling in small cell lung cancer","volume":"16","author":"Wang","year":"2024","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bcp.2026.118322_b0195","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13046-024-03266-7","article-title":"Periostin-mediated NOTCH1 activation between tumor cells and HSCs crosstalk promotes liver metastasis of small cell lung cancer","volume":"44","author":"Lou","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118322_b0200","article-title":"TGF\u03b21 in cancer-associated fibroblasts is associated with progression and radiosensitivity in small-cell lung cancer","volume":"9","author":"Zhang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bcp.2026.118322_b0205","article-title":"The LDH-H3K18La-Nur77 axis potentiates immune escape in small cell lung cancer","author":"Shang","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.bcp.2026.118322_b0210","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41467-019-13601-8","article-title":"O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth","volume":"11","author":"Nie","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118322_b0215","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13046-023-02688-z","article-title":"Regulating lactate-related immunometabolism and EMT reversal for colorectal cancer liver metastases using shikonin targeted delivery","volume":"42","author":"Long","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118322_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108994","article-title":"The role of glycolysis and lactate in the induction of tumor-associated macrophages immunosuppressive phenotype","volume":"110","author":"Zhang","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2026.118322_b0225","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.medj.2024.06.002","article-title":"Preclinical study and phase II trial of adapting low-dose radiotherapy to immunotherapy in small cell lung cancer","volume":"5","author":"Wang","year":"2024","journal-title":"Med"},{"key":"10.1016\/j.bcp.2026.118322_b0230","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1186\/s12967-025-06450-1","article-title":"Dynamic Evolution and antitumor mechanisms of CXCR6+CD8+ T cells in small cell lung cancer treated with low-dose radiotherapy and immunotherapy","volume":"23","author":"Lin","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bcp.2026.118322_b0235","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1038\/s41467-025-57257-z","article-title":"PARP inhibitor radiosensitization enhances Anti-PD-L1 immunotherapy through stabilizing chemokine mRNA in small cell lung cancer","volume":"16","author":"Ran","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118322_b0240","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s43018-022-00456-0","article-title":"Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect","volume":"3","author":"Nishiga","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.bcp.2026.118322_b0245","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1158\/2326-6066.CIR-17-0581","article-title":"Exosomes shuttle TREX1-sensitive IFN-stimulatory dsDNA from irradiated cancer cells to DCs","volume":"6","author":"Diamond","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bcp.2026.118322_b0250","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2217\/imt-2021-0050","article-title":"Abscopal effect of radiation therapy and nivolumab in a patient with combined small-cell lung cancer: a case report","volume":"14","author":"Wang","year":"2022","journal-title":"Immunotherapy"},{"key":"10.1016\/j.bcp.2026.118322_b0255","doi-asserted-by":"crossref","first-page":"15618","DOI":"10.1038\/ncomms15618","article-title":"DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity","volume":"8","author":"Vanpouille-Box","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118322_b0260","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.21037\/tlcr-24-33","article-title":"CDK4\/6 Inhibitor abemaciclib combined with low-dose radiotherapy enhances the anti-tumor immune response to PD-1 blockade by inflaming the tumor microenvironment in Rb-deficient small cell lung cancer","volume":"13","author":"Wang","year":"2024","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.bcp.2026.118322_b0265","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ijrobp.2025.04.011","article-title":"Stimulator of interferon genes agonist synergistically amplifies programmed cell death protein-1 blockade and radiation-induced systemic antitumor responses via tumor microenvironment enrichment","volume":"123","author":"Zheng","year":"2025","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bcp.2026.118322_b0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-022-01695-6","article-title":"MicroRNA-1 attenuates the growth and metastasis of small cell lung cancer through CXCR4\/FOXM1\/RRM2 axis","volume":"22","author":"Khan","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2026.118322_b0275","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41392-022-01127-3","article-title":"Tobacco carcinogen induces tryptophan metabolism and immune suppression via induction of indoleamine 2,3-dioxygenase 1","volume":"7","author":"Liang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2026.118322_b0280","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1038\/s41467-020-17750-z","article-title":"Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-kynurenine","volume":"11","author":"Campesato","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118322_b0285","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.73699","article-title":"Engineered natural killer cells impede the immunometabolic CD73-adenosine axis in solid tumors","volume":"11","author":"Chambers","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.bcp.2026.118322_b0290","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004660","article-title":"Protein kinase inhibitor ceritinib blocks ectonucleotidase CD39\u2014a promising target for cancer immunotherapy","volume":"10","author":"Sch\u00e4kel","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bcp.2026.118322_b0295","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.156623","article-title":"Lysosomal acid lipase, CSF1R, and PD-L1 determine functions of CD11c+ myeloid-derived suppressor cells","volume":"7","author":"Zhao","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.bcp.2026.118322_b0300","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1038\/s41598-024-52687-z","article-title":"Dynamic phenotypic reprogramming and chemoresistance induced by lung fibroblasts in small cell lung cancer","volume":"14","author":"Lu","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.118322_b0305","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.bbrc.2019.05.118","article-title":"Kdm1a promotes SCLC progression by transcriptionally silencing the tumor suppressor rest","volume":"515","author":"Jin","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2026.118322_b0310","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aau2922","article-title":"Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition","volume":"12","author":"Augert","year":"2019","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bcp.2026.118322_b0315","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jtho.2022.05.014","article-title":"Targeting lysine-specific demethylase 1 rescues major histocompatibility complex class i antigen presentation and overcomes programmed death-ligand 1 blockade resistance in SCLC","volume":"17","author":"Nguyen","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bcp.2026.118322_b0320","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1158\/1078-0432.CCR-22-1128","article-title":"Inhibition of LSD1 with bomedemstat sensitizes small cell lung cancer to immune checkpoint blockade and T-cell killing","volume":"28","author":"Hiatt","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118322_b0325","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1878-0261.13124","article-title":"Intrinsic and acquired drug resistance to LSD1 inhibitors in small cell lung cancer occurs through a TEAD4-driven transcriptional state","volume":"16","author":"Yan","year":"2022","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bcp.2026.118322_b0330","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1158\/1078-0432.CCR-23-3383","article-title":"A phase I\/II study of valemetostat (DS-3201b), an EZH1\/2 inhibitor, in combination with irinotecan in patients with recurrent small-cell lung cancer","volume":"30","author":"Choudhury","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118322_b0335","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.chembiol.2023.09.001","article-title":"Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapy","volume":"31","author":"Yu","year":"2024","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.bcp.2026.118322_b0340","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1158\/0008-5472.CAN-21-1991","article-title":"Plasticity in the absence of NOTCH uncovers a RUNX2-dependent pathway in small cell lung cancer","volume":"82","author":"Hong","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118322_b0345","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adf7006","article-title":"Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancers","volume":"15","author":"Quintanal-Villalonga","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bcp.2026.118322_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e38572","article-title":"Potential Immunologic and prognostic roles of CHRNA6 in SCLC and pan-cancer","volume":"10","author":"Zhao","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.bcp.2026.118322_b0355","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyaf256","article-title":"Efficacy outcomes between tarlatamab and real-world physicians' choice of therapies for previously treated extensive stage small cell lung cancer","volume":"30","author":"Wang","year":"2025","journal-title":"Oncologist"},{"key":"10.1016\/j.bcp.2026.118322_b0360","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cllc.2025.03.006","article-title":"Real-world outcomes of tarlatamab in small cell lung cancer, including patients with untreated brain metastases","volume":"26","author":"Bolte","year":"2025","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.bcp.2026.118322_b0365","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1158\/1078-0432.CCR-20-2845","article-title":"AMG 757, a half-life extended, DLL3-targeted bispecific T-cell engager, shows high potency and sensitivity in preclinical models of small-cell lung cancer","volume":"27","author":"Giffin","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118322_b0370","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1158\/1078-0432.CCR-20-0926","article-title":"A bispecific DLL3\/CD3 IgG-Like T-cell engaging antibody induces antitumor responses in small cell lung cancer","volume":"26","author":"Hipp","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118322_b0375","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1158\/2326-6066.CIR-23-0638","article-title":"Engineering CD3\/CD137 dual specificity into a DLL3-targeted T-cell engager enhances T-cell infiltration and efficacy against small-cell lung cancer","volume":"12","author":"Mikami","year":"2024","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bcp.2026.118322_b0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101198","article-title":"Molecular subtype changes after acquiring resistance to tarlatamab in small cell lung cancer","volume":"79","author":"Ahn","year":"2025","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bcp.2026.118322_b0385","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003897","article-title":"Targeting disialoganglioside GD2 with chimeric antigen receptor-redirected T cells in lung cancer","volume":"10","author":"Reppel","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bcp.2026.118322_b0390","doi-asserted-by":"crossref","DOI":"10.1172\/JCI166028","article-title":"IL-18-secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models","volume":"133","author":"Jaspers","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.118322_b0395","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.omtm.2020.10.020","article-title":"The TOP vector: a new high-titer lentiviral construct for delivery of sgRNAs and transgenes to primary T cells","volume":"20","author":"Humes","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.bcp.2026.118322_b0400","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.omto.2022.02.024","article-title":"CD3 engagement as a new strategy for allogeneic \u201coff-the-shelf\u201d T cell therapy","volume":"24","author":"Li","year":"2022","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.bcp.2026.118322_b0405","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004935","article-title":"Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry","volume":"10","author":"Nguyen","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bcp.2026.118322_b0410","doi-asserted-by":"crossref","first-page":"e00041","DOI":"10.1128\/jvi.00041-25","article-title":"TRIM56 enhances adenoviral E1A steady state to improve oncolytic adenovirus therapy efficacy","volume":"99","author":"Sun","year":"2025","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2026.118322_b0415","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1172\/JCI121323","article-title":"Oncolytic virotherapy for small-cell lung cancer induces immune infiltration and prolongs survival","volume":"129","author":"Kellish","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.118322_b0420","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.cmet.2021.09.002","article-title":"Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming","volume":"33","author":"Morrissey","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2026.118322_b0425","doi-asserted-by":"crossref","first-page":"26858","DOI":"10.1021\/acsnano.4c08117","article-title":"Spatiotemporal delivery of dual nanobodies by engineered probiotics to reverse tumor immunosuppression via targeting tumor-derived exosomes","volume":"18","author":"Qin","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.bcp.2026.118322_b0430","article-title":"Precision tumor immunotherapy via a dual-gated macrophage-bacterial activation platform","author":"Li","year":"2025","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.bcp.2026.118322_b0435","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1021\/acs.accounts.3c00771","article-title":"Nanomedicines for an enhanced immunogenic cell death-based in situ cancer vaccination response","volume":"57","author":"Zhao","year":"2024","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bcp.2026.118322_b0440","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1158\/1078-0432.CCR-20-0851","article-title":"Molecular engineering of ultrasmall silica nanoparticle-drug conjugates as lung cancer therapeutics","volume":"26","author":"Madajewski","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118322_b0445","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202412730","article-title":"Lysosome targeted nanoparticle aggregation reverses immunosuppressive tumor microenvironment for cancer immunotherapy","volume":"36","author":"Xing","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bcp.2026.118322_b0450","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adj3945","article-title":"STING licensing of type I dendritic cells potentiates antitumor immunity","volume":"9","author":"Wang","year":"2024","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.bcp.2026.118322_b0455","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ccell.2021.12.009","article-title":"MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells","volume":"40","author":"Limagne","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2026.118322_b0460","doi-asserted-by":"crossref","first-page":"537","DOI":"10.7150\/ijbs.89080","article-title":"Cisplatin-induced pyroptosis enhances the efficacy of PD-L1 inhibitor in small-cell lung cancer via GSDME\/IL12\/CD4Tem axis","volume":"20","author":"Xuzhang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bcp.2026.118322_b0465","article-title":"MYC activation impairs cell-intrinsic IFN\u03b3 Signaling and confers resistance to Anti-PD1\/PD-L1 therapy in lung cancer","volume":"4","author":"Alburquerque-Bejar","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.bcp.2026.118322_b0470","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd1524","article-title":"Immunotherapy combinations overcome resistance to bispecific T cell engager treatment in T cell-cold solid tumors","volume":"13","author":"Belmontes","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bcp.2026.118322_b0475","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.7150\/thno.98819","article-title":"Theranostics with somatostatin receptor antagonists in SCLC: correlation of 68Ga-SSO120 PET with immunohistochemistry and survival","volume":"14","author":"Mavroeidi","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.bcp.2026.118322_b0480","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3390\/biomedicines12040809","article-title":"PBMCs as tool for identification of novel immunotherapy biomarkers in lung cancer","volume":"12","author":"De Rosa","year":"2024","journal-title":"Biomedicines"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:15:56Z","timestamp":1788812156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226006611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":96,"alternative-id":["S0006295226006611"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118322","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How diverse therapeutic strategies reshape the tumor immune microenvironment in small cell lung cancer: from radiation to engineered immunotherapies","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118322","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118322"}}